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Upon exposure to stress, tRNAs are enzymatically
cleaved, yielding distinct classes of tRNA-derived
fragments (tRFs). We identify a novel class of tRFs
derived from tRNAGlu, tRNAAsp, tRNAGly, and tRNATyr
that, upon induction, suppress the stability of multi-
ple oncogenic transcripts in breast cancer cells by
displacing their 30 untranslated regions (UTRs) from
the RNA-binding protein YBX1. This mode of post-
transcriptional silencing is sequence specific, as
these fragments all share a common motif that
matches the YBX1 recognition sequence. Loss-of-
function and gain-of-function studies, using anti-
sense locked-nucleic acids (LNAs) and synthetic
RNAmimetics, respectively, revealed that these frag-
ments suppress growth under serum-starvation,
cancer cell invasion, and metastasis by breast can-
cer cells. Highly metastatic cells evade this tumor-
suppressive pathway by attenuating the induction
of these tRFs. Our findings reveal a tumor-suppres-
sive role for specific tRNA-derived fragments and
describe a molecular mechanism for their action.
This transcript displacement-based mechanism
may generalize to other tRNA, ribosomal-RNA, and
sno-RNA fragments.INTRODUCTION
Transfer RNA-derived RNA fragments (tRFs) belong to a family of
short non-coding RNAs (ncRNAs) present in most organisms.
These RNAs can be both constitutively generated and produced
in the context of stress. Constitutive tRFs are thought to arise
from ribonucleolytic processing of tRNAs by Dicer (Cole et al.,
2009) and RNase Z (Lee et al., 2009). The generation of stress-
induced tRFs, also known as stress-induced fragments (tiRNAs),
has been shown to occur via the action of specific ribonucleases
such as Angiogenin (Fu et al., 2009). Although tRNAs are one of
the most abundant ncRNA molecules in the cell (10% of total
cellular RNA), only a small fraction of tRNAs are cleaved to pro-
duce tRFs (Thompson and Parker, 2009). Multiple classes of
tRFs have been identified in various cell types and organisms
and induced by various conditions. These classes are defined
by the position of the tRNA cleavage site that gives rise to790 Cell 161, 790–802, May 7, 2015 ª2015 Elsevier Inc.tRFs, and these classes include 50- and 30-tRNA halves (cleaved
in the anti-codon loop), 50- and 30-tRFs (also known as 30CCA
tRF), and 30U tRFs, among others (Gebetsberger and Polacek,
2013).
Stress-induced tRFs have been reported to mediate a stress
response, which results in stress granule assembly and inhibition
of protein synthesis (Emara et al., 2010). Moreover, these tRFs
can impact a number of cellular functions, such as cell prolifera-
tion and mediating RNA inactivation through Argonaute engage-
ment (Gebetsberger and Polacek, 2013). In this study, we sought
to investigate whether tRFs could play a role in metastatic pro-
gression. We reasoned that tRFs could have roles in cancer pro-
gression analogous to those of specific microRNAs (Krol et al.,
2010). We also reasoned that because hypoxia is a major stress
encountered by cells during cancer progression, tRFs induced
under hypoxic conditions may act to curb metastatic pro-
gression. By employing next-generation small-RNA (smRNA)
sequencing, we identified a group of tRFs that were upregulated
under hypoxia in breast cancer cells as well as in non-trans-
formed mammary epithelial cells. Interestingly, highly metastatic
breast cancer cells did not display induction of these tRFs under
hypoxia, suggesting a potential role for these molecules in can-
cer progression. We identified a common sequence motif pre-
sent in these hypoxia-induced fragments, suggesting they may
interact with a common trans factor. By using one of these
tRFs (tRFGlu) as bait, we immunoprecipitated and identified the
RNA-binding protein YBX1 as a trans factor whose mRNA-stabi-
lizing activity is repressed by these fragments.
YBX1 is a versatile RNA-binding protein with a variety of inter-
acting partners. It is involved in many key cellular pathways,
and its genetic inactivation leads to embryonic lethality (Uchiumi
et al., 2006). Importantly, it is highly overexpressed in multiple
cancer types (Ju¨rchott et al., 2010; Matsumoto and Bay, 2005;
Wu et al., 2012). By combining molecular, biochemical, and
computational approaches, we find that tRFs bind YBX1 and
displace a number of known oncogenic transcripts from YBX1,
thereby antagonizing YBX1 activity. YBX1 stabilizes these onco-
genic transcripts and mediates their enhanced expression. The
displacement of these oncogenic transcripts by tRFs represses
their stability and expression—thereby suppressing metastatic
progression.
RESULTS
Systematic Identification of tRFs in Breast Cancer Cells
Tumor cells encounter various cellular stresses during the course
of cancer progression. A critical stress is reduced access to
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Figure 1. Genome-wide Profiling of tRFs in
Breast Cancer MDA-231 Cells under Normal
and Hypoxic Conditions
(A) The linear motif SCUBYC was enriched in RNA
fragments mapping to tRNA loci that were upregu-
lated in MDA-parental cells, but not MDA-LM2 cells,
under hypoxic conditions. Shown are the mutual
information values and their associated Z scores for
the discovered motif in both cell lines (Elemento
et al., 2007). The enrichment score (positive for
enrichment and negative for depletion), presented
as logP (hypergeometric p value), is also shown as a
heatmap with blue showing depletion and yellow
showing enrichment of the SCUBYC motif among
the sequences in each cluster. The red border marks
statistical significance of the enrichment score.
(B) The levels of tRFs derived from tRNAGlu were
significantly enhanced under hypoxic conditions in
MDA-parental cells but not in MDA-LM2 cells. The
log fold-change was calculated from the smRNA
sequencing data. The p value was calculated using
Wilcoxon rank-sum test. Two exemplary tRFs that
contain the SCUBYC motif are also indicated.
(C) Streptavidin beads were used to co-precipitate
proteins interacting with a 30-biotinylated synthetic
tRFGlu mimetic and scrambled oligonucleotide
in vivo. YBX1was identified as a potential interacting
partner based on the identity of the annotated RNA-
protein complexes enriched among the tRFGlu co-
precipitated RNA-binding proteins.
(D) 30-biotinylated synthetic oligonucleotides were
used to co-precipitate YBX1. In addition to the
scrambled RNA, a tRNAAla-derived fragment, which
does not carry the identifiedmotif, was also included
as control. Western blotting was performed to
detect YBX1 in the eluate from each sample.
(E) MDA-LM2 cells were transfected with a 21 nt synthetic tRFGlu mimetic (unlabeled), also shown are scrambled transfected mimetic and untransfected cells as
controls. After crosslinking immunoprecipitation of endogenous YBX1, and radiolabeling of the RNA population, a strong interaction between the transfected
tRFGlu mimetic and endogenous YBX1 was observed.
Error bars in all panels indicate SEM unless otherwise specified.oxygen, a condition known as hypoxia (Moyer, 2012; Wilson and
Hay, 2011). Multiple regulatory programs are co-opted by tumor
cells to counteract the negative impacts of hypoxic stress (Bris-
tow and Hill, 2008). For example, the stabilization and activation
of the transcription factor HIF1a under hypoxia results in the acti-
vationof vascular endothelial growth factor (VEGF, angiogenesis;
Shen andKaelin, 2013), GLUT1 (glucose transport), and carbonic
anyhydrase IX (CA9, pH regulation; Semenza, 1999). Recently, it
was reported that tRFs are produced under hypoxia and during
other stress conditions (Fu et al., 2009). Given the ability of hyp-
oxia to significantly modulate the regulatory landscape of the
cell at both transcriptional and post-transcriptional levels, we
searched for tRNA fragments with potential regulatory roles
that are modulated under hypoxic conditions in cancer cells. To
do so, we performed smRNA sequencing of breast cancer cells
(MDA-MB-231, hereafter termed MDA-parental). We observed
that a sizeable fraction (4%) of the smRNA population origi-
nated from tRNAs and therefore could be categorized as tRFs.
We observed > 10 smRNA reads mapping to each of more than
300 tRNA loci across these samples.
tRFs belong to a class of smRNAs that are generated through
endonucleolytic cleavage of tRNAs (Gebetsberger and Polacek,2013; Thompson and Parker, 2009). These fragments have been
detected in bacteria, yeast, and mammalian cells under normal
and stress conditions (Gebetsberger and Polacek, 2013; Lee
et al., 2009). Although tRNA fragments were first detected in
the urine of cancer patients more than three decades ago, and
at the time were proposed to be oncogenic molecules (Borek
et al., 1977; Speer et al., 1979), their roles and mechanisms of
action during cancer progression remain uncharacterized.
Consistent with their potential roles in stress response, tRF
levels in breast cancer cells significantly increased under hypox-
ia (p < 1e6, Figure S1A). Interestingly, the induction of these
fragments by hypoxia was significantly blunted in MDA-LM2
cells—a highlymetastatic sub-population derived through in vivo
selection from the MDA-parental population (Figure S1A; Minn
et al., 2005). These findings suggested that highly metastatic
cells evade the upregulation of these fragments under hypoxic
conditions. Sequence analysis of the tRNAs with hypoxia-
induced fragmentation revealed the significant enrichment of a
common linear sequence motif (SCUBYC; Figure 1A). This motif
was not significantly enriched in the tRNA loci whose fragments
were upregulated in highly metastatic MDA-LM2 cells, further
highlighting the absence of a concerted upregulation of theseCell 161, 790–802, May 7, 2015 ª2015 Elsevier Inc. 791
tRFs in highly metastatic cells (Figures 1A and S1A). The identi-
fication of this sequence motif among hypoxia-induced tRFs in
MDA-parental cells raised the possibility that this element serves
as a binding site for a common trans factor that potentially
interacts with these small ncRNAs in vivo. For example, among
tRNAGlu-derived fragments, which were significantly upregu-
lated under hypoxia in MDA-parental but not MDA-LM2 cells,
several tRF species carried instances of the SCUBYC sequence
motif described above (Figure 1B). In order to identify the
unknown trans factor that may recognize this sequence motif,
we used synthetic oligonucleotides from tRNAGlu as bait in an
in vitro co-precipitation experiment. A 21 nt 30-biotinylated oligo-
nucleotide carrying an instance of the identified motif was immo-
bilized on streptavidin beads and was subsequently used to co-
precipitate the interacting protein complexes. A scrambled RNA
was processed in parallel as the control to measure the co-pre-
cipitation of proteins above background. In-solution digestion
followed by mass-spectrometry was employed to determine
the identity of the co-precipitated proteins. Gene-set enrichment
analysis revealed that proteins annotated as components of
‘‘ribonucleoprotein complex’’ and ‘‘stress granule complex’’
were significantly over-represented among co-precipitated pro-
teins (Figure 1C). YBX1, which showed 5-fold enrichment above
background (Figure S1B), is the only protein that shares both of
these annotations (Figure 1C); as such, we chose to further study
this RNA-binding protein as a candidate tRF-interacting protein.
To validate this interaction, we performed reciprocal co-immu-
noprecipitations and detected binding of YBX1 to an exoge-
nously transfected 30-biotinylated tRFGlu mimetic, but not to
the scrambled RNA or tRFAla controls (Figure 1D). Consistently,
we also detected the binding of endogenous YBX1 to the tRFGlu
mimetic, but not the scrambled RNA control (Figure 1E).
Specific tRFs Interact with YBX1
YBX1, a multifunctional RNA-binding protein and a member of
the Y box-binding protein family, has been implicated in various
aspects of RNA biology. Importantly, it is a known modulator of
RNA translation and stability and has been implicated in tiR-
NAAla-mediated inhibition of ribosomal activity in vivo (Ivanov
et al., 2011). Consistently, while resolving YBX1-crosslinked
RNAs on a polyacrylamide gel, we observed a prominent smRNA
band in addition to longer RNA species interacting with YBX1
(Figures 1E and S1C). We hypothesized that in addition to tRFGlu,
which was used as bait to identify YBX1, YBX1 may also interact
with a broader population of endogenous smRNAs in the cell. To
generate a detailed and precise snapshot of genome-wide
YBX1-RNA interactions across long- and short RNA species,
we performed crosslinking immunoprecipitation of endogenous
YBX1 followed by high-throughput sequencing (CLIP-seq) in hu-
manMDA-parental breast cancer cells. Analysis of the CLIP-seq
data provided us with the first in vivo YBX1 transcript interac-
tome revealing more than 4,000 endogenous transcripts bound
by YBX1. The majority of YBX1-binding sites were localized to
30 untranslated regions (30 UTRs) and exons, whereas minimal
binding was detected in 50 UTRs and in intronic sequences (Fig-
ure 2A). A large number of cellular processes and pathways,
including RNA processing, translation, cell cycle, glucose catab-
olism, spindle organization, and additional key signaling and792 Cell 161, 790–802, May 7, 2015 ª2015 Elsevier Inc.stress-response pathways, were over-represented among the
YBX1-bound transcripts (Figure S1D). The breadth and diversity
of the YBX1 regulon (Figures S1E and S1F) highlight its role in
RNA homeostasis and growth, as well as its importance for
cellular response to internal and external stimuli.
Consistent with our observation regarding the interaction be-
tween tRFGlu and YBX1 in vivo, high-throughput sequencing of
the YBX1-crosslinked smRNAs (smRNA CLIP-seq) revealed
that the majority of these CLIP-seq tags mapped to tRNA loci
and represented tRFs (Figures 2A, S2A, and S2B). We observed
that YBX1 interacts with a specific subset of tRFs present in
these cells. For example, tRFGlyTCC and tRFAspGTC, both with
relatively low cellular expression levels, displayed substantial
binding to YBX1, whereas highly expressed fragments, tRFLysTTT
and tRFSerAGA, were absent among the YBX1 smRNA CLIP-seq
tags (Figure S2C). A more global comparison is provided in Fig-
ure 2B in which the relative abundance of tRNA fragments map-
ping to each tRNA locus in MDA-parental cells is shown relative
to those from the YBX1 smRNA CLIP-seq. These findings reveal
that the interactions between tRFs and YBX1 were not simply a
function of tRF abundance in the cell and that YBX1 binding to
tRFs is specific and dependent on factors other than tRF levels
(e.g., sequence specificity). Based on our YBX1 smRNA CLIP-
seq experiment, we identified a number of specific tRFs as
most abundantly bound by YBX1; chief among them, the tRNA-
Glu, tRNAAsp, and tRNAGly fragments that mapped to the anti-
codon loops of these tRNAs and a tRNATyr-derived fragment
matching the intron-containing precursor of this tRNA
(Figure 2C).
Transcriptomic profiling under normoxic and hypoxic condi-
tions in both control and YBX1 knockdown cells revealed that
in the MDA-parental breast cancer cells, YBX1-bound tran-
scripts were significantly enriched among those downregulated
under hypoxia in a YBX1-dependent manner (Figure 2D). This
observation suggested the presence of a hypoxia-induced
and YBX1-mediated post-transcriptional regulatory program.
Gene-expression analysis of non-tumorigenic mammary epithe-
lial MCF10a cells under hypoxia also showed an enrichment of
YBX1-bound transcripts among the hypoxia-induced downre-
gulated genes, further strengthening this hypothesis (Z score =
5.7; data not shown). More importantly, highly metastatic
MDA-LM2 cells did not exhibit YBX1-dependent downregulated
expression of the target transcripts under hypoxia, consistent
with their lack of induction of specific hypoxia-induced tRFs (Fig-
ure 2D). Given that YBX1 did not show a significant change in
expression in MDA-LM2 cells relative to the MDA-parental line
(Figure S2D), we hypothesized that the observed enrichment
may be mediated by tRFs, which are induced in poorly metasta-
tic but not highly metastatic cells (Figure S1A).
Our findings described above reveal a direct physical interac-
tion between tRNAGlu fragments and YBX1 (Figures 1D and 1E).
In order to validate the in vivo interaction between the other
tRFs and YBX1, we developed a cell-based competition experi-
ment, based on quantitative PCR (qPCR) assays of smRNAs,
in which chemically synthesized tRF mimetics were used to
compete with endogenous fragments for YBX1 binding in vivo.
We designed specific primers for reliable qPCR-mediated detec-
tion of tRFGlu, tRFAsp, and tRFGly in this competition assay. Under
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Figure 2. Endogenous YBX1 Interacts with a Large Regulon of Transcripts and smRNAs In Vivo
(A) Pie charts depicting the annotation of YBX1-binding sites obtained from immunoprecipitation of endogenous YBX1 from RNase-treated lysate of UV-
irradiated MDA-parental cells followed by high-throughput sequencing of both long- and smRNAs.
(B) Relative frequency of reads mapped to each tRNA locus in MDA-parental smRNA sequencing and YBX1 smRNA CLIP-seq. The tRF species most abundantly
bound by YBX1 are marked.
(C) Based on the YBX1 smRNA CLIP-seq results, four species of tRFs bound by YBX1 in vivo were identified. Shown are examples of tRNA structures for each
species depicting the boundaries of the identified tRFs along with the YBX1-binding region based on smRNA YBX1 CLIP-seq read density at each position (also
see Figure S2A). The gray nucleotides at the 30 end mark the presence of terminal CCA sequences. The dark gray highlights for tRNATyrGTA mark the leader and
intronic sequences in the unprocessed tRNA. The longest identified forms of each tRF based on our high-throughput sequencing results are also indicated (gray
highlight) along with the YBX1 smRNA CLIP-seq read density at each position (overlaid as a heatmap) indicating the YBX1-binding site.
(D) Gene-expression profiling of control and YBX1 knockdown cells was performed under normal and hypoxic conditions in both MDA-parental and MDA-LM2
backgrounds. The set of transcripts that was downregulated under hypoxia in a YBX1-dependent manner was identified for each cell line. Although YBX1-bound
transcripts were significantly enriched among YBX1-dependent hypoxia-induced downregulated transcripts inMDA-parental cells, this enrichment was absent in
the highly metastatic MDA-LM2 cells.
(E) qPCR-based validation of interactions between YBX1 and tRFAspGTC, tRFGluYTC, and tRFGlyTCC. Cells transfected with exogenous tRF mimetics were
subjected to UV crosslinking and YBX1 immunoprecipitation. The abundance of each tRF in the co-immunoprecipitated RNA population was then measured
using a smRNA qPCR-based quantitation assay (n = 3–4).
Statistical significance ismeasured using a one-tailed Student’s t test: *p < 0.05, **p < 0.01, and ***p < 0.001. Error bars in all panels indicate SEMunless otherwise
specified.the assumption that exogenous tRFseffectively bindYBX1 in vivo
(as was shown for tRFGlu), we predicted that the increase in
cellular levels of a specific tRF would result in the subsequent
displacement of other tRNA fragments from the endogenous
YBX1-bound RNA population. To test this hypothesis, we UV-
irradiated cells transfectedwith synthetic tRFs or scrambled con-
trols, immunoprecipitated YBX1 under stringent CLIP-seq condi-
tions (Ule et al., 2005), andusedqPCR todetect theabundanceof
each specific tRF in the YBX1-bound fraction. Consistent with
active binding of YBX1 to synthetic tRFs, we observed that exog-
enous transfection of a given tRF led to depletion of the other as-sayed endogenous tRF species in every case (Figure 2E). This
quantitative assay demonstrates not only that these tRF species
bind YBX1 but also that they compete for YBX1 binding in vivo.
Moreover, as was the case for tRFGlu, we used 30-biotinylated
short oligonucleotides mimicking tRFAsp and tRFGly to co-immu-
noprecipitate interacting proteins from total cell lysates. We
observed significant enrichment in endogenous YBX1 protein
levels upon co-immunoprecipitation of the tRFs relative to a 30-
biotinylated scrambledoligonucleotide (FigureS2E). Importantly,
we also observed a significant upregulation in tRFGlu, tRFAsp, and
tRFGly under hypoxic conditions, quantified using tRF-specificCell 161, 790–802, May 7, 2015 ª2015 Elsevier Inc. 793
qPCR in both MDA-parental breast cancer cells and MCF10a
non-transformed mammary epithelial cells (Figures S2F and
S2G). Consistent with our prior findings, this induction was ab-
sent in metastatic MDA-LM2 cells (Figure S2H). While these
YBX1-binding tRFs are constitutively expressed, their levels are
enhanced in the context of hypoxic stress. This observation indi-
cates that the tRFs identified here can be categorized as tRNA-
derived stress-induced RNAs (tiRNAs) and likely play roles in
stress responses. More importantly, the absence of their induc-
tion in highly metastatic MDA-LM2 cells highlights the potential
suppressive roles theymayplayduringbreast cancermetastasis,
in which tRFs must be antagonized for metastasis to progress.
tRF-Mediated Post-Transcriptional Modulation
through YBX1
Previous studies have established a role for another class
of tRNA fragments—tRNA 50-halves (e.g., 50-tiRNAAla and 50-tiR-
NACys)—in translation inhibition. These fragments were found to
cause translation initiation factors to disengage from mRNAs
(Ivanov et al., 2011). This translational inhibition effect was
shown to be YBX1 dependent. The molecular mechanism
through which this previously identified class of tRFs modulates
YBX1 interaction with translation initiation factors remains to be
elucidated. YBX1 has also been implicated in other post-tran-
scriptional regulatory programs,most notably transcript stability.
We set out to test whether functional interactions between tRFs
and YBX1 affect expression levels of endogenous transcripts.
We envisioned two plausible molecular mechanisms through
which tRFs may affect YBX1 binding to mRNAs in vivo (Fig-
ure S3A). First, in a tRF-mediated transcript engagement model,
a given tRF may act as a guide RNA whereby the YBX1-tRF
complex binds specific target transcripts based on sequence
complementarity to the bound tRF, in a manner similar to
miRNA-mediated binding of transcripts by Argonaute. In this
scenario, reducing tRF levels would lead to reduced YBX1
binding of transcripts. Second, in a tRF-mediated transcript
displacement model, YBX1 would interact with tRFs andmRNAs
alike, in which case tRFs would be actively competing with
endogenous transcripts for YBX1 binding. In this model,
reducing tRF levels would lead to greater YBX1 binding of its
target mRNAs. Importantly, in the transcript engagement model,
mRNAs carrying the reverse-complement of the tRF sequence
would be affected in terms of YBX1-binding abundance or
expression, whereas in the transcript displacement model, only
the transcripts that contain YBX1-binding motifs would be
affected by tRF modulation. In order to distinguish between
these two molecular mechanisms, we utilized synthetic anti-
sense locked-nucleic acids (LNAs) targeting the YBX1-binding
site (based on the smRNA CLIP-seq peaks; Figures S2A and
S2B) on the most abundantly bound tRFs—namely, tRFAsp,
tRFGly, tRFGlu, and tRFTyr (Figure 2B). We used specific anti-
sense LNAs to bind and inhibit the endogenous forms of these
tRFs individually in order to observe their effects on the tran-
scriptome relative to a scrambled LNA control. Importantly, to
specifically focus on transcripts impacted by tRF inhibition
through their direct interaction with YBX1, we conducted
whole-transcriptome profiling of both control and YBX1 knock-
down cells transfected with anti-sense LNAs (Figure S3B).794 Cell 161, 790–802, May 7, 2015 ª2015 Elsevier Inc.We first sought to identify the YBX1-binding sequences on
these four tRFs in order to observe the behavior of mRNAs car-
rying these sequences (transcript displacement model) or their
complementary sequences (transcript engagement model). We
made no assumptions about the YBX1-binding site on RNAs,
instead opting to test all possible 8-mers (and their reverse com-
plements) along the identified binding sites on each of the four
tRFs (sequences shown in Figure 3A). Each 8-mer was assessed
for (1) its enrichment (or that of its reverse complement sequence)
in 30 UTRs of transcripts that were deregulated in a YBX1-depen-
dent manner in each experiment (see Experimental Procedures)
and (2) its enrichment amongYBX1-binding sites on endogenous
transcripts (YBX1CLIP-seq). For each tRF, we successfully iden-
tified an 8-mer that was enriched in both (1) the 30 UTRs of tran-
scripts upregulated (not downregulated) in a YBX1-dependent
manner and (2) theYBX1CLIP-sites onendogenousmRNAs (Fig-
ures 3A and 3B). Given that in each case, it was the specific
8-mer, rather than its reverse complement, that was functionally
bound by YBX1 in vivo, the YBX1 modulation of transcript levels
observedhere is consistentwith themodelwherein tRFsdisplace
transcripts from YBX1. In this competition-based model, the
binding of specific tRFs to YBX1 is inhibited by LNA transfection,
allowing free YBX1 to interact with YBX1-binding sites on endog-
enous transcripts. Increased YBX1 binding would result in higher
transcript abundances,most likely through enhancedmRNAsta-
bilization by YBX1 in vivo. Subsequently, we provide additional
genomic, molecular, and biochemical evidence that supports
this YBX1-dependent post-transcriptional mode of regulation.
In order to determine a consensus binding site for YBX1 on
tRFs and mRNAs, we performed multiple alignments for the
8-mers that were independently identified for each tRF. The re-
sulting sequencemotif, namedCU-boxbasedon theprominence
of a C andU at the second and third positions along the identified
regular expression representation of the element (Figure 3C),
was significantly enriched among CLIP-seq tags in both YBX1
smRNA (p < 0.002) and long RNA (mRNA) CLIP-seq datasets
(p < 1080; Figure 3D). Importantly, this element resembles an
in vitro YBX1-binding motif described previously (Figure S3C).
Moreover, tracking cross-linking-induced mutation sites (CIMS;
Zhang and Darnell, 2011), which mark protein-RNA interactions
at single-nucleotide resolution, at and around CU-box elements
(10 flanking nucleotides) across the YBX1 CLIP sites revealed
that the cross-linked nucleotides were most frequent at the site
of the motif (Figure S3D). This observation further supports a
direct physical interaction between YBX1 and CU-box elements.
Taken together, our results indicate that YBX1 interactswith both
endogenous target transcripts and tRFs via the CU-box element.
It should also be noted that the SCUBYC motif identified in Fig-
ure 1A constitutes a specific subset of the CU-box element
described here (CompareACE score of 0.85). The commonality
of the binding site would enable tRFs to competitively modulate
the levels of YBX1 available for transcript binding, which would
in turn affect the expression of a large set of target transcripts.
Competitive tRF Binding to YBX1 Results in Transcript
Destabilization
In addition to the anti-sense LNA-mediated tRF loss-of-func-
tion experiments followed by transcriptomic profiling, we also
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Figure 3. YBX1 Interacts with Long- and smRNAs via a Specific Linear Sequence Motif
(A) The transcripts upregulated upon anti-sense LNA transfections targeting each of the four identified tRFs were compared to the remainder of the transcriptome
(background) to identify over-representation of specific sequence elements in their 30 UTRs. Here, we have shown the enrichment of specific 8-mers along each
YBX1-bound tRF in the 30 UTRs of these transcripts as a heatmap, with yellow and blue showing the extent of enrichment and depletion, respectively (red and blue
borders mark statistical significance). Also shown are the associated mutual information values and Z scores (Elemento et al., 2007). We have provided the
sequence of each tRF and highlighted the identified 8-mers.
(B) These 8-mers were also required to be enriched among the YBX1-binding sites identifiedwith CLIP-seq.We used a shuffled version of each YBX1-binding site
to create a background set and tested the enrichment of each 8-mer in the YBX1-binding sites relative to shuffled controls.
(C) In order to infer a consensus element for YBX1 on these tRFs, the four significant 8-mers were aligned, and the possible nucleotides at each position were
combined to build the CU box element represented as a regular expression.
(D) The CU boxmotif showed a significant enrichment in both long- and smRNAYBX1 CLIP-seq data sets relative to randomly shuffled sequences, indicating that
YBX1 binds a common linear sequence motif on both short and long endogenous RNAs.
Error bars in all panels indicate SEM unless otherwise specified.transfected control and YBX1 knockdown cells with synthetic
tRF mimetics in gain-of-function experiments delineated in Fig-
ure S3E. For this, we performed two separate experiments; in
one, we transfected control and YBX1 knockdown cells with
the mimetics representing the long form of each identified tRF
(Figures 2C and S2B), and in another, we used 20 nucleotide
short synthetic tRF mimetics containing the identified YBX1-
binding sites. Although YBX1-bound transcripts (and transcripts
with CU boxes in their 30 UTRs) were significantly upregulated
upon LNA transfections (Figures 4A, S4A, and S4B), these tran-
scripts were significantly downregulated in the context of tRF
mimetic transfection in a YBX1-dependent manner (Figures 4B,
4C, S4C, and S4D). These observations reveal that (1) exoge-
nously transfected tRF mimetics act as modulators of the YBX1
regulon, and (2) short tRF mimetics carrying the YBX1-binding
site are sufficient for exerting this regulatory effect.
To determine whether the observed YBX1-dependent tRF-
mediated modulations in YBX1 target transcripts’ levels were
occurring post-transcriptionally, we performed whole-genometranscript stability measurements. Through a-amanitin-based
inhibition of RNA polymerase II in anti-sense LNA-transfected
control and YBX1 cells, we found that the observed increase in
YBX1-targeted transcript abundance resulted from a significant
enhancement of their stabilities in a YBX1-dependent manner
(Figures 4D, S4E, and S4F). This observation further establishes
the role of these YBX1-tRF interactions as a coherent and
functional post-transcriptional regulatory program (Figure S4G).
Importantly, the changes observed in the expression of YBX1-
dependent transcripts upon transfection of anti-sense LNAs or
tRF mimetics were significantly anti-correlated (Figure S4H).
Further supporting this model, we also observed a reduction in
total RNA bound to YBX1 upon transient transfection of an exog-
enous tRFGlu mimetic (Figure S5A).
Target-Specific Validation of a Role for tRF-YBX1 in
Transcript Destabilization
Whole-genome expression and stability measurements support
a transcript displacement model for tRF-YBX1 interaction,Cell 161, 790–802, May 7, 2015 ª2015 Elsevier Inc. 795
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Figure 4. Endogenous Transcripts Bound by YBX1 Are Modulated by YBX1-Bound tRFs
In order tomeasure the post-transcriptional regulatory consequences of tRFs, gain-of-function and loss-of-function experiments were performed by transfecting
synthetic tRF mimetics or inhibitory anti-sense LNAs, for each of the four YBX1-binding tRFs, in normal and YBX1 knockdown cells. Transcripts that were up- or
downregulated in a YBX1-dependent manner were identified by comparing the gene-expression changes in normal cells relative to those in YBX1 knockdown
cells (Figure S3). Transcripts that interact with YBX1 in vivo (determined from YBX1 CLIP-seq data) were significantly de-regulated upon modulations of tRF
levels: (A) they were upregulated upon LNA-mediated inhibition of YBX1-binding tRFs; (B and C) they were downregulated in the presence of exogenously added
short and long tRF mimetics (60 and 20 nucleotides, respectively; see Figure S2B), and (D) the observed upregulation in the LNA-transfected cells coincided
with a significant increase in their stability. Whole-genome transcript stability measurements were performed in LNA-transfected cells using a-amanitin-mediated
inhibition of RNA polymerase II followed by RNA extraction and profiling at 0 and 8 hr time points. In all data sets, the calculated mutual information values (in bits)
and their associated p values are provided. Also shown are the enrichment scores, presented as logP (positive for enrichments and negative for depletions),
where P is calculated from hypergeometric distribution (shown as a heatmap with blue and gold showing depletion and enrichment, respectively). The red and
blue borders mark statistical significance of the enrichment/depletions. Error bars in all panels indicate SEM unless otherwise specified.wherein tRFs effectively compete with endogenous transcripts
for YBX1 binding. In order to independently validate our obser-
vations for a specific set of targets, we chose HMGA1, CD151,
CD97, and TIMP3 for target-specific follow-up experimental
validation based on pervasive in vivo interactions with YBX1
along their 30 UTRs (Figure 5A). Transfection of tRF-specific
anti-sense LNAs significantly upregulated and stabilized these
transcripts (Figures 5B and 5C).More importantly, their observed
upregulation was abrogated in YBX1 knockdown cells (Figures
5B and 5C).796 Cell 161, 790–802, May 7, 2015 ª2015 Elsevier Inc.As mentioned earlier, under hypoxic conditions, in which the
YBX1-bound tRFs were shown to be upregulated in MDA-
parental cells (Figure 2C), we observed a concomitant downre-
gulation of YBX1 target transcripts (Figure 2D). Importantly,
this hypoxia-induced YBX1-dependent downregulation, which
was absent in highly metastatic MDA-LM2 cells, was diminished
once hypoxic cells were transfected with anti-sense LNAs (Fig-
ure S5B). We also observed a similar expression pattern for
HMGA1, CD97, and TIMP3 transcripts when tested under hyp-
oxia and normoxia in both control and YBX1 knockdown cells
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Figure 5. YBX1 Target Transcripts and Their
Response to Changes in tRF Levels
(A) YBX1 interacts with the 30 UTRs of HMGA1,
CD151, CD97, and TIMP3. The last exon of the
indicated transcripts are shownwithmapped reads
from experimental replicates of YBX1 CLIP-seq.
(B) Transfection of anti-sense LNAs against YBX1-
binding tRFs resulted in the upregulation of
HMGA1, CD151, CD97, and TIMP3 transcripts, in a
YBX1-dependent manner, as determined by qPCR
measurements.
(C) Similarly, transfecting anti-sense LNAs resulted
in a significant stabilization of HMGA1, CD97, and
TIMP3 transcripts in a YBX1-dependent manner.
Whole-genome RNA stability measurements were
performed using a-amanitin-mediated inhibition of
RNA polymerase II (see Experimental Procedures).
(D) A GFP/mCherry dual-reporter assay was used
to measure the effects of cloning HMGA1, CD97,
and part of the TIMP3 30 UTRs downstream of
mCherry using qRT-PCR. The 30 UTR of MAPK14,
which is devoid of YBX1 tags, was included as a
control. Consistent with our prior findings, LNA
transfections resulted in a significant increase in
relative mCherry expression in a YBX1-dependent
manner.
(E) Exogenously added tRF mimetics, although
showing no effect onMAPK14 abundance, resulted
in a significant depletion of HMGA1, CD97, and
TIMP3 transcripts from the YBX1 co-immunopre-
cipitated RNA population.
Statistical significance is measured using a one-
tailed Student’s t test: *p < 0.05, **p < 0.01, and
***p < 0.001. Error bars in all panels indicate SEM
unless otherwise specified.in MDA-parental and MDA-LM2 backgrounds (Figure S5C).
Consistently, we found that the 30 UTR sequences of these tran-
scripts cloned downstream of a bi-directional reporter construct
were sufficient to confer YBX1-dependent upregulation of the re-
porter upon transfection of anti-sense LNAs targeting the four
selected tRFs (Figure 5D). The MAPK14 30 UTR, which was not
bound by YBX1 as assessed by CLIP-seq, served as a compar-
ative control. Importantly, the YBX1 dependence of this tRF-
mediated response to LNA transfection further supports a role
for YBX1 in stabilizing target transcripts through binding of 30
UTR elements (Figure 5D).
Consistent with our proposed tRF-mediated transcript
displacement model, we also observed that transfecting tRF
mimetics into cells followed by YBX1 co-immunoprecipitation
depleted HMGA1, TIMP3, and CD97 transcripts from the
YBX1-bound RNA population (Figure 5E). This observation
further supports direct competition between tRFs and endoge-
nous transcripts for YBX1 binding in vivo.Cell 161, 790tRF-Mediated Modulation of Cancer
Progression and Metastasis
YBX1 has been implicated in cancer pro-
gression. YBX1 overexpression is corre-
lated with tumorigenic phenotypes and
has also been shown to promote cancermetastasis (Ju¨rchott et al., 2010; Matsumoto and Bay, 2005;
Uchiumi et al., 2006; Wu et al., 2012). Given the role of tRFs in
suppressing the expression of YBX1 target genes, we hypothe-
sized that this class of smRNAs may act to suppress cancer
progression. For example, a tRF-YBX1 signature based on the
average expression of roughly 70 YBX1-bound transcripts with
robust modulations in response to anti-sense LNA or tRF
mimetic transfections was found to be significantly associated
with cancer stage as well as relapse-free survival of patients
with breast cancer (Figures S6A and S6B). The entire YBX1-
tRF regulon—defined as the subset of endogenous transcripts
that are bound by YBX1 in vivo and whose expression is modu-
lated by the transfection of tRF mimetics and anti-sense LNAs in
a YBX1-dependent manner—contains hundreds of transcripts,
including many known promoters of tumorigenesis and metas-
tasis, such as AKT, EIF4G1, ITGB4, and HMGA1 (Figures 6A
and S6C). We also noted highly significant associations between
increased expression of multiple tRF-YBX1 targets that are key–802, May 7, 2015 ª2015 Elsevier Inc. 797
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Figure 6. YBX1-Binding tRFs Play a Signifi-
cant Role in Modulating Oncogenes
(A) Competitive displacement of YBX1 from its
target transcripts by tRFs resulted in the down-
regulation of a large set of oncogenes and
metastasis promoter genes.
(B–D) Kaplan-Meier curves for three translation
initiation factors that were modulated by tRFs via
YBX1 binding (Gyorffy et al., 2012).
(E) Exogenously added tRF mimetics or anti-sense
LNAs resulted in a significant increase and
decrease in cancer cell invasion, respectively.
Shown are the fold-changes in cancer cell invasion
for MDA-parental cells transfected with LNAs
and MDA-LM2 cells transfected with tRFs. We
have also included representative fields from the
invasion inserts along with the median of cells
observed in each cohort (n = 7–8).
(F) Growth rates (estimated based on an expo-
nential model) under serum-starved conditions for
MDA-LM2 cells transfected with tRF mimetics
relative to mock-transfected cells (n = 6).
(G) qRT-PCR assays were used to quantify the
levels of tRFAsp, tRFGlu, and tRFGly in metastatic
(n = 18) and non-metastatic (n = 9) primary breast
cancers.
For comparing growth under serum-starved con-
ditions, two-way ANOVA was used to measure
statistical significance. For all other cases, statis-
tical significance was measured using one-tailed
Student’s t test: *p < 0.05, **p < 0.01, and ***p <
0.001. Error bars in all panels indicate SEM unless
otherwise specified.components of translation initiation (EIF4G1, EIF4EBP1, and
EIF3B) and reduced relapse-free survival (p = 8e12, 1e16,
and 2e13, respectively; n = 3455; Figures 6B–6D). The tran-
scripts of these oncogenes, which play roles in various aspects
of cellular function, including translation and cell signaling,
were repressed by tRFs in breast cancer cells (Figure 6A). Trans-
fection of anti-sense LNAs targeting the tRFs into MDA-parental
and CN-parental cancer cells significantly enhanced cell inva-798 Cell 161, 790–802, May 7, 2015 ª2015 Elsevier Inc.sion capacity in vitro (Figures 6E and
S6D). Conversely, transfection of tRF
mimetics into metastatic MDA-LM2 and
CN-LM1a lines significantly reduced can-
cer cell invasion (Figures 6E and S6D).
We also observed a substantial decrease
in cell proliferation rate under serum-
starved conditions in the presence of
these tRFs, further highlighting their roles
as components of a general stress-
response pathway (Figure 6F). These
tRFs were ineffective at suppressing
these phenotypes in cells depleted of
YBX1—consistent with a required role
for YBX1 in modulating these tRF-medi-
ated responses (Figures S6E and S6F).
Importantly, we also detected tRFAsp,
tRFGlu, and tRFGly in RNA samples frommetastatic and non-metastatic primary tumors as well as
normal breast tissue. Consistent with a tumor-suppressive
role for these tRFs, their levels were significantly lower in breast
cancer tissue relative to normal breast tissue (Figure S6G).
Moreover, if these specific tRFs suppress metastatic progres-
sion, we would expect that there would be a selection for
reduced expression of these tRFs during this process. Indeed,
we observed a significant trend toward reduced tRF levels in
metastatic samples compared to primary tumors (p = 0.003,
n = 27; Figure 6G).
To demonstrate the physiological relevance of this hypoxia-
induced tRF-YBX1 pathway, we used a reporter driving the
expression of luciferase under a hypoxia response promoter (Fig-
ure S7A). Consistent with MDA-parental breast cancer cells
experiencing hypoxia early in the metastatic process in the lungs
of xenografted mice, cells carrying this reporter exhibited induc-
tion of the hypoxia-induced pathway 24 hr post-injection (Fig-
ure S7B). To probe the in vivo expression of tRF-YBX1 targets,
we constructed a lentiviral system with firefly luciferase reporter
fused to 30 UTRs of CD97 and TIMP3 (tRF-YBX1 targets) as
well as MAPK14 (as a control). Consistent with YBX1 stabilizing
these transcripts by binding to their 30 UTRs, immediately after in-
jection, we observed a significantly lower luciferase activity for
CD97 and TIMP3 30 UTRs in YBX1 knockdown cells (Figure S7C).
More importantly, the CD97 and TIMP3 reporters showed signif-
icantly lower day3 today0 luciferase activity ratios in control cells
compared toYBX1 knockdown cells (Figure S7D). These findings
are consistent with the in vivo induction of tRFs under hypoxia
and the YBX1 dependence of the associated response. It should
be highlighted that this reduction was absent in the luciferase re-
porter carrying the control MAPK14 30 UTR (Figure S7D).
Consistent with the observed clinical associations and our
in vitro as well as in vivo findings, transfection of tRF mimetics
and anti-sense LNAs significantly impacted metastatic coloniza-
tion in in vivo lung colonization assays by multiple independent
cell lines. MDA-parental cells transfected with anti-sense LNAs
exhibited significantly higher metastatic colonization activity
relative to cells transfected with scrambled controls (Figures
7A and S7E). Similarly, transfection of inhibitory anti-sense
LNAs in CN-parental cells also caused a marked and significant
increase in metastatic colonization of the lungs (Figures 7B and
S7E). In contrast, exogenous transfection of tRF mimetics into
highly metastatic lines (MDA-LM2 and CN-LM1a cells) signifi-
cantly reduced cancer metastasis to the lungs (Figures 7C, 7D,
and S7E). We also tested and validated the impact of tRF mod-
ulation on the metastatic activity of a third human breast cancer
cell-line—HCC1806 (Figures 7E and S7E). It should be noted that
in these in vivo lung colonization assays, a clear and significant
difference in the normalized signal could be detected early in
the in vivo experiments (Figure S7F). This early impact on metas-
tasis is in part consistent with the role of tRFs in cancer cell inva-
sion, which is an early determinant of metastatic progression.
This early difference persists throughout the experiment despite
the dilution of mimetics and anti-sense LNAs (Figure S7G), and
the two cohorts fail to converge. Importantly, consistent with a
YBX1-dependent mode of action, depleting YBX1 from cancer
cells using RNAi made cells insensitive to tRF-mediatedmodula-
tion of metastatic activity (Figure S7H).
DISCUSSION
By integrating biochemical, molecular, computational, and
phenotypic analyses, we have found that a specific set of tRFs
functionally engages the oncogenic RNA-binding protein
YBX1. These fragments, which contain a CU box motif, post-
transcriptionally suppress the expression of YBX1 transcriptsby competitively displacing them from YBX1. We find that
YBX1 binds and promotes the stability of a large set of
transcripts, thus modulating a large regulon with broad conse-
quences for cellular function. Our study reveals the first compre-
hensive and in vivo interaction map between YBX1, one of the
most overexpressed oncogenes observed in human cancer
(upregulated in 10% of all cancer versus normal tissue data
sets; Oncomine), and its post-transcriptional target transcripts
(Lasham et al., 2012; Uchiumi et al., 2006; Wu et al., 2012).
A number of these transcripts encode established drivers of
oncogenesis, such as EIF4G1, ITGB4, AKT1, and ADAM8.
YBX1 stabilization of oncogenic transcripts is mediated by its
binding to CU box motifs, which are primarily located in the 30
UTRs of transcripts. The displacement of oncogenic transcripts
from YBX1 results in their destabilization and downregulation.
Consistent with a tumor-suppressive role for these YBX1-antag-
onistic smRNAs, their introduction into breast cancer cells
inhibited breast cancer growth under serum starvation, cell inva-
sion, and metastasis. Conversely, inhibiting these fragments by
anti-sense LNAs enhanced these phenotypes.
This tRF-mediated displacement mechanism of post-tran-
scriptional silencing involving the binding of specific tRFs to
YBX1 differs from RNAi-mediated silencing in that small tRNA
fragments do not serve as guides for transcript engagement by
YBX1. Rather, they competitively displace and thus destabilize
YBX1-bound transcripts. Our findings expand the repertoire of
endogenous smRNA-mediated post-transcriptional modes of
regulation that have been previously described (RNAi, micro-
RNA, and CeRNA; Karaca et al., 2014; Lujambio and Lowe,
2012; Salmena et al., 2011).
Our findings reveal that a specific set of fragments contain tu-
mor-suppressive and metastasis-suppressive activity. We pro-
pose that these fragments are generated as a result of oncogenic
stress as an internal mechanism for tumor suppression. We
speculate that during breast cancer evolution, two mechanisms
counter this smRNA-mediated tumor-suppressive mechanism:
the first being the evasion of the hypoxia-evoked induction of
tumor-suppressive tRFs, and the second being YBX1 upregula-
tion. Consistent with these findings, tRNA fragments were de-
tected at significantly lower levels in metastatic breast cancer
relative to non-metastatic cancers, whereas YBX1 is known to
be upregulated as a function of cancer progression (Lasham
et al., 2012).
We find that the repressive effects of these endogenous tRNA
fragments on the abundance and stability of oncogenic tran-
scripts is moderate in scale. Nonetheless, our loss-of-function
and gain-of-function studies involving these fragments reveal
robust in vitro and in vivo effects resulting from their modulation
in breast cancer. We believe that these effects result from the
coordinated post-transcriptional control of a large set of YBX1-
dependent oncogenes whose concomitant suppression results
in robust phenotypic effects. These observations parallel those
seen withmicroRNAs implicated in cancer progression—moder-
ate post-transcriptional suppressive effects on groups of tran-
scripts involved in common oncogenic processes (Lujambio
and Lowe, 2012).
An association between YBX1 and tRNA halves has been pre-
viously described (Emara et al., 2010). Transfection of tRNACell 161, 790–802, May 7, 2015 ª2015 Elsevier Inc. 799
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Figure 7. YBX1-Binding tRFs Play a Significant Role as Suppressors of Tumor Progression and Metastasis
(A and B) Bioluminescence imaging plot of metastatic lung colonization by MDA-parental and CN-parental cells transfected with synthetic anti-sense LNAs
against all four YBX1-binding tRFs. Representative images along with quantification of the area-under-the-curve for each mouse are also included (n = 3–5 in
each cohort).
(C and D) Bioluminescence imaging plot of lungmetastasis byMDA-LM2 andCN-LM1a cells transfected with the four YBX1-binding tRFs. Representative images
and area-under-the-curve quantifications are also included (n = 4–5 in each cohort).
(E) Bioluminescence imaging plot of lungmetastasis by HCC1806 cells transfected with the four YBX1-binding tRFs. Representative images and area-under-the-
curve quantifications are also included (n = 5 in each cohort).
(F) Schematic of tRF-mediated modulation of invasion and metastatic lung colonization through in vivo titration of YBX1 and the subsequent destabilization of its
oncogenic and pro-metastatic targets.
For comparing metastasis colonization assays, two-way ANOVA was used to measure statistical significance. For all other cases, statistical significance is
measured using one-tailed Student’s t test: *p < 0.05, **p < 0.01, and ***p < 0.001. Error bars in all panels indicate SEM unless otherwise specified.halves arising from tRNAAla and tRNACys was found to globally
inhibit translation. These tRNA halves were found to repress
translation by 30%, and these effects seemed to result from
the disengagement of translational initiation factor EIF4G1. Addi-
tionally, it was found that the effect of these tRNA halves on
translational repression was YBX1 dependent. These tRNA
halves were found to interact with YBX1, and both fragments
contained a terminal oligoguanine motif. Although molecular
mechanisms for the global inhibition of translation by these
tRNA halves and their in vivo roles have yet to be delineated,800 Cell 161, 790–802, May 7, 2015 ª2015 Elsevier Inc.the authors proposed that these fragments suppress translation
by interfering with EIF4G protein in a YBX1-dependent manner.
Our findings described here reveal a distinct mechanism of ac-
tion by a different class of tRFs. The tRFs we have implicated
belong to a distinct class of fragments and mediate post-tran-
scriptional destabilization of a specific set of transcripts by
directly engaging YBX1 in a sequence-specific manner. Impor-
tantly, our observations regarding the downregulation of elonga-
tion initiation factors at the transcript level are in agreement with
the broad inhibition of translation reported to be induced by a
broader class of tRNA fragments. Moreover, the different mech-
anisms by which distinct classes of tRFs regulate YBX1-depen-
dent gene expression highlight the significance of this stress-
activated regulator in mammalian gene regulation.
Taken together, our findings support a role for endogenous
tRFs in destabilizing oncogenic transcripts through their direct
binding to YBX1. tRF binding of YBX1 leads to displacement of
endogenous oncogenic transcripts from YBX1—resulting in their
destabilization (Figure 7F). Based on this model, specific tRFs
mediate a unique post-transcriptional gene-expression regula-
tory program through their engagement of YBX1. It should be
noted, however, that the regulatory interactions mediated by
tRFs are unlikely to be limited to YBX1, and they likely serve as
a component of a larger regulatory network consisting of various
RNA-binding proteins and small ncRNAs. We should also point
out the possible role of RNA modifications in the functionality
of tRNA fragments. Given that extensive base modifications
in tRNAs are crucial for their function, future studies should
address the potential role of these modifications in tRNA frag-
ments as well. Two lines of evidence in our data suggest a sub-
stantial role for these modifications in modulating the regulatory
effects of endogenous tRFs. First, although the induction of
endogenous tRFs under hypoxia in MDA-parental cells was sub-
stantially more modest than exogenous transfection of synthetic
tRF mimetics, the ensuing YBX1-dependent downregulation of
the tRF-YBX1 regulon was higher in magnitude for endogenous
fragments relative to unmodified transfected mimetics. Second,
consistent with the possible importance of RNA modifications in
tRFs, transfection of anti-sense LNAs that inhibit endogenous
fragments was more potent than that of synthetic mimetics in
eliciting a regulatory response in the cells. This higher potency
of endogenous tRFs relative to synthetic mimetics could be
explained by the presence of RNA modifications that are likely
to affect the structure, stability, and binding affinity of these
fragments.
Although we have shown that the fragments described here
modulate specific phenotypes through transcript displacement
from YBX1, they may also modulate the activity of additional
trans factors. From a broader perspective, we speculate that
fragments arising from other classes of ncRNAs, such as ribo-
somal and sno-RNAs, might mediate similar effects by displac-
ing distinct RNA-binding proteins (or other ncRNAs) from their
endogenous downstream targets.EXPERIMENTAL PROCEDURES
Tissue Culture
HEK293T, MDA-MB-231, and CN34 cells and their derived sub-lines, CN-
LM1a and MDA-LM2, were cultured in DMEM-based media supplemented
with 10% FBS, glutamine, pyruvate, penicillin, streptomycin, and fungizone.
RNAi and DNA transfections were performed using Lipofectamine 2000
(Invitrogen) and TransIT-293 (Mirus), respectively.Exogenous tRF and Anti-Sense LNA Transfection
tRF anti-sense LNA oligonucleotides (Exiqon) or synthetic tRF miemtics (IDT)
were transfected using Lipofectamine 2000 in Reduced Serum Media (Life
Technologies) for a final concentration of 50 nM consisting of equal parts of
each tRF decoy or anti-tRF LNA. After 6 hr of incubation, transfection media
were replaced with fresh media. Cells were subjected to in vitro and in vivostudies 48 hr after transfection. The sequences for the short and long tRF
mimetics are provided in Figure S2B.
Animal Studies
All mouse studies were conducted according to a protocol approved by the
Institutional Animal Care and Use Committee (IACUC) at the Rockefeller
University.
ACCESSION NUMBERS
The data for high-throughput sequencing andmicroarray profiling experiments
are deposited at GEO under the accession number GSE63605.
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Procedures and can be found with this article online at http://dx.doi.org/10.
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